VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
SOOD, ANIL K
One or more keywords matched the following items that are connected to
SOOD, ANIL K
Item Type
Name
Concept
Cisplatin
Academic Article
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.
Academic Article
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
Academic Article
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Academic Article
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Academic Article
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Academic Article
ATP11B mediates platinum resistance in ovarian cancer.
Academic Article
Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
Academic Article
Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
Academic Article
Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma.
Academic Article
Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.
Academic Article
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.
Academic Article
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.
Academic Article
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
Academic Article
Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-diamminedichloroplatinum.
Academic Article
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
Academic Article
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.
Academic Article
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
Academic Article
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
Academic Article
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Academic Article
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.
Academic Article
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
Academic Article
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition.
Academic Article
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Academic Article
Clinical and biological significance of EZH2 expression in endometrial cancer.
Academic Article
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity.
Academic Article
Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304].
Search Criteria
Cisplatin